News
In pharmaphorum's Digital and social media themed month, Daniel Ghinn explores GSK's use of social media and the milestones it has reached to achieve its current success in this space. "There's a ...
Explore how U.S. tariffs and vaccine skepticism may impact GSK plc's profitability. Click for my update as tariffs are ...
GSK is paying to access ABL Bio’s Grabody-B platform, which potentially enables therapies to cross the blood-brain barrier.
CEO Emma Walmsley said the company has been anticipating tariffs on the industry and is “confident” the company can navigate through it, Ashleigh Furlong and Ruth David of Bloomberg reports. The U.S.
GSK plc (LON:GSK – Get Free Report)’s share price passed above its 200-day moving average during trading on Wednesday .The stock has a 200-day moving average of GBX 1,444 ($18.73) and traded ...
Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against GSK plc. ("GSK" or the "Company") (NYSE: GSK). IF YOU ARE AN ...
They don’t know what tariffs mean and they haven’t had them explained ... Jim Cramer was recently asked about GSK plc (NYSE:GSK) in a latest program on CNBC. Here is what Cramer said in ...
On August 10, 2022, Deutsche Bank reported that it seemed “very possible” that GSK “will incur the risk of some degree of shared liability, with the only real questions being what the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results